Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangzhou Onicon Chemical is a Chinese manufacturer and exporter specializing in Active Pharmaceutical Ingredients (APIs), cosmetic additives, and food ingredients. Founded in 1992 and headquartered in Hangzhou, the company serves as a significant production and export hub for the chemical pharmaceutical industry, offering a broad portfolio that includes oncology drugs, cardiovascular agents, and nutritional supplements. Its commercial portfolio features notable APIs such as bortezomib, pimobendan, and melatonin, which are produced in facilities equipped with advanced analytical technologies like NMR and HPLC. The company maintains strategic collaborations with various research institutes and universities to enhance its manufacturing technology and capacity for global distribution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hangzhou Onicon Chemical.